scholarly article | Q13442814 |
P50 | author | Alessio Fasano | Q18686101 |
Terez Shea-Donohue | Q37067154 | ||
Stefanie N. Vogel | Q92126561 | ||
P2093 | author name string | Prasad Rallabhandi | |
Bao Lu | |||
Craig Gerard | |||
Sarah Netzel-Arnett | |||
Karen Thomas | |||
Karen M Lammers | |||
Ruliang Lu | |||
Sefik Alkan | |||
Julie Brownley | |||
Toni Antalis | |||
Amir Tamiz | |||
P2860 | cites work | CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma | Q22254641 |
Toll-like receptor signalling | Q24570126 | ||
Requirement of the chemokine receptor CXCR3 for acute allograft rejection | Q24676298 | ||
Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis | Q28213277 | ||
Identification of tissue transglutaminase as the autoantigen of celiac disease | Q28243044 | ||
Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats | Q33864397 | ||
Danger signals: SOS to the immune system | Q33931055 | ||
Current concepts of celiac disease pathogenesis | Q33964135 | ||
Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure | Q34156588 | ||
The pathogenesis of coeliac disease | Q34273611 | ||
Glutamate receptor ion channels | Q34421735 | ||
Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease | Q34491101 | ||
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. | Q34518641 | ||
Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines | Q34566764 | ||
Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines | Q35047377 | ||
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. | Q35598393 | ||
The tight junction: a multifunctional complex | Q35777543 | ||
Reprogramming of CTLs into natural killer-like cells in celiac disease | Q36238119 | ||
Targeting the chemokine receptor CXCR3 and its ligand CXCL10 in the central nervous system: potential therapy for inflammatory demyelinating disease? | Q36268431 | ||
Regulation of the T cell response | Q36643790 | ||
Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. | Q36765830 | ||
Understanding the molecular basis of celiac disease: what genetic studies reveal | Q36793674 | ||
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis | Q38407325 | ||
Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease | Q40246836 | ||
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function | Q40554316 | ||
Toxicity of Wheat Flour Proteins and Protein-Derived Peptides for In Vitro Developing Intestine from Rat Fetus | Q41137271 | ||
CXCR3 and alphaEbeta7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes | Q41809743 | ||
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. | Q44132607 | ||
Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. | Q46023372 | ||
Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines | Q46722581 | ||
A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation | Q46941338 | ||
gamma/delta T cells in multiple sclerosis: chemokine and chemokine receptor expression | Q48514321 | ||
Human zonulin, a potential modulator of intestinal tight junctions. | Q52162731 | ||
Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. | Q52565792 | ||
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. | Q53912466 | ||
Neutrophil Recruitment and Barrier Impairment in Celiac Disease: A Genomic Study | Q56968899 | ||
Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac disease | Q69122613 | ||
Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brain | Q73315921 | ||
Intraepithelial lymphocytes in celiac disease | Q73555734 | ||
A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor | Q73769783 | ||
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells | Q74321391 | ||
Evidence for NK cell subsets based on chemokine receptor expression | Q79370190 | ||
MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA | Q82616645 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 194-204.e3 | |
P577 | publication date | 2008-07-01 | |
P1433 | published in | Gastroenterology | Q4039279 |
P1476 | title | Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3 | |
P478 | volume | 135 |
Q57534899 | A Grounded Guide to Gluten: How Modern Genotypes and Processing Impact Wheat Sensitivity |
Q38199096 | A metabolomic perspective on coeliac disease. |
Q33990012 | Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil |
Q38126789 | Advances in the treatment of coeliac disease: an immunopathogenic perspective |
Q89687580 | All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases |
Q35895022 | Analysis of Body Composition and Food Habits of Spanish Celiac Women. |
Q37142030 | Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations. |
Q26859130 | Animal models to study gluten sensitivity |
Q34500800 | Anti-gluten immune response following Toxoplasma gondii infection in mice |
Q34676184 | Antibodies to the wheat storage globulin Glo-3A in children before and at diagnosis of celiac disease |
Q57937529 | Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study |
Q57839976 | Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn's disease? |
Q36494385 | Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea |
Q38608380 | Autoimmune diseases and celiac disease which came first: genotype or gluten? |
Q28244133 | Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling |
Q99237719 | Bacteria Remediate the Effects of Food Additives on Intestinal Function in an in vitro Model of the Gastrointestinal Tract |
Q34068869 | Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet- |
Q59813523 | Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies |
Q38919389 | Celiac Disease: Role of the Epithelial Barrier |
Q33696823 | Celiac disease |
Q34367160 | Celiac disease and autoimmune-associated conditions |
Q28290840 | Celiac disease and autoimmunity: review and controversies |
Q38161565 | Celiac disease and endocrine autoimmune disorders in children: an update |
Q37729522 | Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity? |
Q50876572 | Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cells. |
Q42730481 | Celiac disease: Alternatives to a gluten free diet. |
Q92086063 | Celiac disease: a comprehensive current review |
Q34809320 | Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms |
Q37841101 | Celiac disease: a model disease for gene-environment interaction |
Q38669146 | Celiac disease: from etiological factors to evolving diagnostic approaches |
Q34903220 | Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. |
Q22305490 | Celiac disease: prevalence, diagnosis, pathogenesis and treatment |
Q40416734 | Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients |
Q28242747 | Coeliac disease |
Q28266589 | Coeliac disease and autoimmune disease-genetic overlap and screening |
Q64054641 | Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers |
Q89835386 | Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA |
Q27014843 | Current and emerging therapy for celiac disease |
Q47207029 | Cytoplasmic Form of Carlr lncRNA Facilitates Inflammatory Gene Expression upon NF-κB Activation |
Q34022801 | Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells. |
Q60954896 | Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis |
Q26823584 | Dietary gluten and the development of type 1 diabetes |
Q38973710 | Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion |
Q84479921 | Dietary strategies of immunomodulation in infants at risk for celiac disease |
Q35021259 | Digested wheat gluten inhibits binding between leptin and its receptor |
Q36186148 | Discerning the role of Bacteroides fragilis in celiac disease pathogenesis |
Q37067281 | Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. |
Q34668296 | Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity |
Q37704533 | Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet |
Q38080687 | Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis |
Q28069901 | Elderly Onset Celiac Disease: A Narrative Review |
Q38286185 | Emerging drugs for celiac disease |
Q36676716 | Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet. |
Q46057460 | Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease. |
Q35442538 | Epithelial transport of immunogenic and toxic gliadin peptides in vitro |
Q64967668 | Evolving Therapy for Celiac Disease. |
Q34793653 | Gene Expression Profiling of Gliadin Effects on Intestinal Epithelial Cells Suggests Novel Non-Enzymatic Functions of Pepsin and Trypsin |
Q27317169 | Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1 |
Q55471111 | Gliadin Peptide Facilitates FITC Dextran Transport across the Non Everted Gut Sac of Rat Small Intestine. |
Q41951345 | Gliadin fragments promote migration of dendritic cells |
Q26775020 | Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications |
Q43049444 | Gliadins induce TNFalpha production through cAMP-dependent protein kinase A activation in intestinal cells (Caco-2). |
Q48117063 | Gluten-free diet exclusively during pregnancy alleviates the signs of diabetes and celiac disease in NOD mouse offspring |
Q51287171 | Gluten-free diet increases beta-cell volume and improves glucose tolerance in an animal model of type 2 diabetes. |
Q38685400 | Gut Microbiota and Celiac Disease |
Q55342876 | Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease Patients. |
Q35026379 | Hepatic manifestations of celiac disease |
Q51657347 | High levels of immunoglobulin A anti-tissue transglutaminase antibodies at diagnosis are a predictive factor for celiac hepatitis. |
Q34679342 | Human Intestinal Barrier Function in Health and Disease |
Q64064503 | Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease |
Q82527134 | Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease |
Q34612493 | Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2 |
Q34764938 | IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia |
Q47251751 | Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction |
Q38783192 | Immunopathogenesis and therapeutic approaches in pediatric celiac disease |
Q40234173 | Impact of gluten consumption in patients with functional dyspepsia: a case-control study |
Q36344842 | Important lessons derived from animal models of celiac disease. |
Q41881259 | Increased plasma zonulin in patients with sepsis |
Q89553143 | Increasing incidence of inflammatory bowel disease in children and adolescents: the significance of the environmental factors |
Q47999881 | Inhibition of epithelial growth factor receptor signalling does not preserve epithelial barrier function after in vitro gliadin insult |
Q90460272 | Intestinal Barrier Function in Gluten-Related Disorders |
Q38810502 | Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel |
Q28250081 | Intestinal barrier function: molecular regulation and disease pathogenesis |
Q47104884 | Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac disease. |
Q28273316 | Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications |
Q37723494 | Intestinal stem cells and celiac disease |
Q37638684 | Investigational therapies for celiac disease |
Q64261314 | Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damage |
Q37980043 | Is the origin of type 1 diabetes in the gut? |
Q35655989 | Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. |
Q28253767 | Leaky gut and autoimmune diseases |
Q41994459 | Liver involvement in celiac disease |
Q38508755 | Long-term and acute effects of gliadin on small intestine of patients on potentially pathogenic networks in celiac disease |
Q34656866 | Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients. |
Q35785774 | Matriptase protects against experimental colitis and promotes intestinal barrier recovery |
Q55424073 | Microbiota Composition and the Integration of Exogenous and Endogenous Signals in Reactive Nasal Inflammation. |
Q34798574 | Modeling of celiac disease immune response and the therapeutic effect of potential drugs |
Q41173044 | New and developing therapies for celiac disease |
Q22252345 | Non-celiac gluten sensitivity: A work-in-progress entity in the spectrum of wheat-related disorders |
Q26772345 | Nutritional Keys for Intestinal Barrier Modulation |
Q28742767 | Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice |
Q34712071 | Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation. |
Q36943034 | Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall |
Q39111493 | Physiopathology and Management of Gluten-Induced Celiac Disease |
Q59809154 | Possible Prevention of Diabetes with a Gluten-Free Diet |
Q38837940 | Potential role of CXCR3 in proliferation and invasion of prostate cancer cells |
Q34623902 | Prevention measures and exploratory pharmacological treatments of celiac disease. |
Q36218896 | Proinflammatory cytokine interferon-γ and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease |
Q34202899 | Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants |
Q47856590 | Protective Effect of 1,25-Dihydroxy Vitamin D3 on Pepsin-Trypsin-Resistant Gliadin-Induced Tight Junction Injuries |
Q64103840 | RNA sequencing of intestinal mucosa reveals novel pathways functionally linked to celiac disease pathogenesis |
Q84247295 | Recent advances in celiac disease |
Q34287155 | Regulation of intestinal epithelial permeability by tight junctions. |
Q50116104 | Relationship between G proteins coupled receptors and tight junctions |
Q34283907 | Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat |
Q34253519 | Review article: coeliac disease, new approaches to therapy. |
Q35106620 | Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease |
Q30421083 | Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. |
Q47724556 | Screening for celiac disease, by endomysial antibodies, in patients with unexplained hypertransaminasaemia |
Q33823449 | Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder |
Q44117944 | Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease. |
Q47842891 | Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease. |
Q38510131 | Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability |
Q38021639 | Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes |
Q59794324 | The Effect of Dietary Mushroom on Intestinal Microbiota Composition and Host Immunological Function |
Q58604414 | The Effect of Gluten Free Diet on Components of Metabolic Syndrome: A Randomized Clinical Trial |
Q38955820 | The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders |
Q90567912 | The Gut Microbiota in Celiac Disease and probiotics |
Q64905599 | The Influence of Maternal-Foetal Parameters on Concentrations of Zonulin and Calprotectin in the Blood and Stool of Healthy Newborns during the First Seven Days of Life. An Observational Prospective Cohort Study. |
Q35668237 | The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop. |
Q90684083 | The Janus Face of Cereals: Wheat-Derived Prebiotics Counteract the Detrimental Effect of Gluten on Metabolic Homeostasis in Mice Fed a High-Fat/High-Sucrose Diet |
Q37717761 | The Relationship between Serum Zonulin Level and Clinical and Laboratory Parameters of Childhood Obesity |
Q26783642 | The Role of Gluten in Celiac Disease and Type 1 Diabetes |
Q90345025 | The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis |
Q26778458 | The Spectrum of Differences between Childhood and Adulthood Celiac Disease |
Q34332412 | The dietary intake of wheat and other cereal grains and their role in inflammation |
Q28261350 | The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis |
Q26771888 | The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate |
Q27007776 | The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease |
Q34665037 | The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders. |
Q51822901 | The significance of coeliac disease antibodies in patients with ankylosing spondylitis: a case-controlled study. |
Q26825413 | Therapeutic approaches for celiac disease |
Q28249095 | Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms |
Q37638199 | Tissue-mediated control of immunopathology in coeliac disease |
Q45940827 | Toxic peptides in Frazer's fraction interact with the actin cytoskeleton and affect the targeting and function of intestinal proteins. |
Q89896536 | Transcriptional and Ultrastructural Analyses Suggest Novel Insights into Epithelial Barrier Impairment in Celiac Disease |
Q38269678 | Transglutaminase as a therapeutic target for celiac disease |
Q52358106 | Translational Chemistry Meets Gluten-Related Disorders. |
Q37125463 | What role does wheat play in the symptoms of irritable bowel syndrome? |
Q34315374 | Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4 |
Q90565703 | Wheat gluten intake increases the severity of experimental colitis and bacterial translocation by weakening of the proteins of the junctional complex |
Q90257092 | Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity |
Q38830164 | Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model |
Q39103865 | Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases |
Q34283930 | Zonulin, regulation of tight junctions, and autoimmune diseases |
Q279074 | gliadin | described by source | P1343 |
Search more.